Metabolic-Fit / 100
SkinnyRx review
A flat $199/mo semaglutide and $299/mo tirzepatide, with a real non-injection option most of this batch skips: sublingual tablets for both molecules — but the FDA issued its parent entity, Lean Rx, Inc., a warning letter on 02/20/2026 (ref. 717989) for mislabeling itself as the compounder on its own product images and for marketing language implying its compounded products share FDA-approved status with Mounjaro and Zepbound, which they don't. Confirmed directly on FDA.gov; SkinnyRx's own site never mentions it.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Referral link, walled off from the score
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
SkinnyRx at a glance
- Semaglutide
- $199/mo
- Tirzepatide
- $299/mo
- Coverage
- Not disclosed on the public site we reviewed
- Brand-name
- Compounded only
How we scored SkinnyRx
Every factor comes from SkinnyRx's own published pricing, disclosures and oversight, and the six combine into the 37/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- skinnyrx.com
$199 for injectable semaglutide, $249 for the sublingual tablets, and $299 for tirzepatide in either form. No state list and no exclusions are published anywhere on the public site, which is the main thing left unanswered before you start.
What to expect when you sign up
We walked SkinnyRx's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The site's structured product data lists a single flat price per form (injectable or tablet) for each molecule
- 2Complete an online quiz-based intake
- 3A licensed provider reviews and prescribes if appropriate
- 4Medication ships if approved
What we noticed
- Offers a genuine choice most of this batch doesn't: sublingual tablets alongside the injectable, for both molecules
- The site's own code carries an internal flag literally named "no_membership" alongside its pricing — consistent with a flat medication price and no separate membership fee
- The price is not in the page's own text — it appears only after the page's scripts run, so a reader with scripts blocked sees no price at all
- No state list or exclusions are published anywhere we could find on the public site
- The site itself makes no mention of its own FDA warning letter — that fact came from FDA.gov, not SkinnyRx's own copy
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $199 | Injectable |
| Oral semaglutide | $249 | Sublingual tablets |
| Compounded tirzepatide | $299 | Injectable |
| Oral tirzepatide | $299 | Sublingual tablets |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what SkinnyRx's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Offers sublingual tablets as a genuine alternative to injections for both molecules — uncommon in this batch
- Flat pricing regardless of dose ($199/$299 injectable; $249/$299 tablets)
- Internal site code carries a "no_membership" flag consistent with no separate fee stacked on the medication price
The caveats
- No state list or exclusions published anywhere on the public site
- Pricing only surfaces in the site's compiled app data, not in a plain page read — a transparency gap for anyone checking without technical tools
- No mention anywhere of pregnancy, breastfeeding, postpartum recovery, or PCOS
- The FDA issued its parent company, Lean Rx, Inc., an FDA warning letter dated 02/20/2026 (ref. 717989) for mislabeling itself as the compounder on its own product images and for marketing claims implying its compounded products share FDA-approved status with brand-name drugs like Mounjaro and Zepbound, which they don't — confirmed on FDA.gov, and never mentioned anywhere on SkinnyRx's own site
SkinnyRx for mothers: our verdict
A flat $199/mo semaglutide and $299/mo tirzepatide, with a real non-injection option most of this batch skips: sublingual tablets for both molecules — but the FDA issued its parent entity, Lean Rx, Inc., a warning letter on 02/20/2026 (ref. 717989) for mislabeling itself as the compounder on its own product images and for marketing language implying its compounded products share FDA-approved status with Mounjaro and Zepbound, which they don't. Confirmed directly on FDA.gov; SkinnyRx's own site never mentions it. It runs about $199/month, flat across every dose.
We weigh SkinnyRx the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What SkinnyRx costs, in full
- Compounded semaglutide — Injectable: $199/mo
- Oral semaglutide — Sublingual tablets: $249/mo
- Compounded tirzepatide — Injectable: $299/mo
- Oral tirzepatide — Sublingual tablets: $299/mo
That lands within a few dollars of the ~$179/month median across the providers we track, so the monthly cost isn't what should decide this one either way. Weigh it instead on postpartum and breastfeeding timing and PCOS and insulin resistance, and on what the price actually includes — a lower number that leaves out labs, visits or shipping is not the cheaper option.
On that last point SkinnyRx is no help: it doesn't break down what the monthly figure covers — whether the provider visit, shipping and any lab work are inside it or billed separately. Ask before you pay, because that answer is what decides whether a mid-range price is actually mid-range.
The medications SkinnyRx prescribes
SkinnyRx prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
A needle-free oral or sublingual option is on the menu, which draws in mothers who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.
Where SkinnyRx fits — and where it doesn't — for mothers
A good fit if…
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- a clean regulatory record is a dealbreaker — note the FDA warning flagged in the cons above.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. It carries an FDA warning letter, flagged in the cons — read it before starting. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
SkinnyRx is a provider we list only with full disclosure — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers willing to verify SkinnyRx's compounding and ingredient claims for themselves rather than take its labels or marketing at face value — the FDA found the site misrepresents who actually compounds these products and implies an FDA-approved status they don't have. Read the FDA's letter before you weigh in the tablet option or the flat pricing.
Alternatives to SkinnyRx
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing SkinnyRx
Head-to-head & alternatives
SkinnyRx, answered
- Does SkinnyRx offer a non-injection option?
- Yes — sublingual tablets are available for both semaglutide ($249/mo) and tirzepatide ($299/mo), alongside the injectable forms ($199/mo and $299/mo).
- Does SkinnyRx charge a separate membership fee?
- Its own site code carries an internal flag named "no_membership" alongside its pricing data, consistent with a flat medication price with nothing stacked on top — though this wasn't confirmed through a live checkout.
- Does SkinnyRx have an FDA warning letter?
- Yes — the FDA issued one dated 02/20/2026 (ref. 717989) to Lean Rx, Inc., SkinnyRx's legal entity, after reviewing skinnyrx.com in December 2025. It found the site's product labels falsely display "SkinnyRx" as the compounder of its semaglutide and tirzepatide products, and that marketing lines like "from the same family as GLP-1 treatments like Mounjaro and Zepbound" wrongly imply FDA-approved status for products that don't have it. We confirmed this directly on FDA.gov; SkinnyRx's own site makes no mention of it.
Pricing, states and verification reflect SkinnyRx's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.